Skip to Content

Revenio Group Oyj REVXF

Morningstar Rating
$28.35 −6.45 (18.53%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

REVXF is trading at a 797% premium.
Price
$28.35
Fair Value
$94.15
Uncertainty
High
1-Star Price
$21.18
5-Star Price
$73.23
Economic Moat
Tbhhq
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if REVXF is a good fit for your portfolio.

Trading Information

Previous Close Price
$34.80
Day Range
$28.3528.35
52-Week Range
$28.3544.00
Bid/Ask
$29.14 / $34.14
Market Cap
$753.55 Mil
Volume/Avg
835 / 835

Key Statistics

Price/Earnings (Normalized)
35.46
Price/Sales
7.17
Dividend Yield (Trailing)
1.43%
Dividend Yield (Forward)
1.43%
Total Yield
1.43%

Company Profile

Revenio Group Oyj is a Finnish health technology company. It develops and commercializes effective and easy-to-use health tech-related screening devices for the detection of diseases of significance to public health. Its ophthalmic diagnostic solutions includes intraocular pressure (IOP) measurement devices (tonometers), perimeter and fundus imaging devices under the iCare brand. Its eye care software platform Oculo offers clinical communication, telehealth, remote patient monitoring, and data analytics capabilities. The company's geographical segments include Finland, Other Europe, and Others.
Sector
Healthcare
Industry
Medical Devices
Stock Style Box
Small Growth
Total Number of Employees
216

Comparables

Valuation

Metric
REVXF
NORDH
OKDAV
Price/Earnings (Normalized)
35.4663.11
Price/Book Value
6.752.821.21
Price/Sales
7.175.930.12
Price/Cash Flow
35.03218.528.33
Price/Earnings
REVXF
NORDH
OKDAV

Financial Strength

Metric
REVXF
NORDH
OKDAV
Quick Ratio
1.912.390.52
Current Ratio
2.442.390.77
Interest Coverage
60.96−1,270.38−4.02
Quick Ratio
REVXF
NORDH
OKDAV

Profitability

Metric
REVXF
NORDH
OKDAV
Return on Assets (Normalized)
13.85%−10.46%−2.60%
Return on Equity (Normalized)
19.53%−11.87%−13.30%
Return on Invested Capital (Normalized)
18.70%−12.17%−7.05%
Return on Assets
REVXF
NORDH
OKDAV
See how this stock stacks up to its competitors with Morningstar Investor

Medical Devices Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Abbott Laboratories
ABT
PmfynzwmLczsdx$182.1 Bil
Stryker Corp
SYK
VdwpmdhxtMgjy$127.5 Bil
Boston Scientific Corp
BSX
ZjgffpypNvrfvvh$113.8 Bil
Medtronic PLC
MDT
MkkllqvFsjcnx$104.2 Bil
Edwards Lifesciences Corp
EW
WzqzhmjmmGshwlpp$52.6 Bil
DexCom Inc
DXCM
VzsbmwkrGxr$45.4 Bil
Koninklijke Philips NV ADR
PHG
KnzrdgmvBhnvwj$24.2 Bil
Zimmer Biomet Holdings Inc
ZBH
MgbmyfpbtmYml$22.8 Bil
Steris PLC
STE
GdhnykpqnWpsckx$22.6 Bil
Align Technology Inc
ALGN
GlqqtpkjFhcgq$18.9 Bil

Sponsor Center